
Shareholding20 Oct 2026, 04:14 pm
Genomic Valley Biotech: Promoter Sells 46.06% Stake, Open Offer Triggered
AI Summary
Genomic Valley Biotech Limited announced that its promoter, Mr. Yogesh Agrawal, has entered into a Share Purchase Agreement (SPA) dated October 19, 2026, to sell his entire shareholding of 14,07,000 equity shares, representing 46.06% of the voting share capital, to Mr. Pankaj Grover and Mr. Abhisek Gupta. This transaction will result in the acquirers gaining control of the company and will trigger an open offer obligation to the public shareholders as per SEBI (SAST) Regulations. The existing promoter directors are expected to resign post-transaction. The acquirers are not related to the existing promoter group and the transaction is not considered a related party transaction.
Key Highlights
- Promoter Mr. Yogesh Agrawal to sell entire 46.06% stake.
- Acquirers Mr. Pankaj Grover and Mr. Abhisek Gupta to gain control.
- Transaction triggers mandatory open offer to public shareholders.
- Existing promoter directors to resign post-completion.
Price Impact
More from GVBL